title: Complete clinical and virological remission of refractory HIV-related Kaposi's sarcoma with pegylated interferon alpha.
authors.forename: Marchina
authors.initials: M
authors.lastname: van der Ende
authors.forename: Jan Willem
authors.initials: JW
authors.lastname: Mulder
authors.forename: Marcel
authors.initials: M
authors.lastname: van den Berge
authors.forename: Willem
authors.initials: W
authors.lastname: Blok
authors.forename: Martin
authors.initials: M
authors.lastname: Schutten
mesh_terms: D000328:Adult; D023241:Antiretroviral Therapy, Highly Active; D000998:Antiviral Agents / Q000627:therapeutic use*; D005260:Female; D015658:HIV Infections / Q000150:complications*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D008297:Male; D011092:Polyethylene Glycols; D011994:Recombinant Proteins; D012514:Sarcoma, Kaposi / Q000188:drug therapy*; D016896:Treatment Outcome
chemical_list: D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; C417083:peginterferon alfa-2b